+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Injectable Drugs Delivery - Global Strategic Business Report

  • PDF Icon

    Report

  • 192 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805778
The global market for Injectable Drugs Delivery was estimated at US$1.0 Trillion in 2023 and is projected to reach US$2.0 Trillion by 2030, growing at a CAGR of 10.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

What Is the Scope of Injectable Drug Delivery, and Why Is It Crucial?


Injectable drug delivery refers to the administration of drugs directly into the body through a needle or similar device, bypassing the gastrointestinal tract. This method is particularly crucial for drugs that are poorly absorbed orally or are unstable in the digestive system. Injectable drug delivery is widely used for its rapid onset of action, which is essential in emergency care and chronic disease management. It is also the preferred method for the administration of certain biologics, vaccines, and drugs that require precise dosing. The development of advanced injection technologies, such as auto-injectors and pen injectors, has greatly enhanced patient compliance and safety, making it easier for patients to self-administer medications accurately and painlessly.

How Are Technological Advancements Transforming Injectable Drug Delivery?


The field of injectable drug delivery is being transformed by technological advancements that aim to improve the safety, efficacy, and comfort of drug administration. Innovations include the development of needle-free injection systems, which use high-pressure jets to deliver drugs through the skin without the use of needles, reducing pain and the risk of needle-stick injuries. Smart injectors that provide feedback on dosage and injection technique are also gaining popularity, ensuring that patients administer their medications correctly. Additionally, sustained-release formulations are being developed to reduce the frequency of injections needed, enhancing convenience for patients with chronic conditions.

What Challenges and Opportunities Are Associated with Injectable Drug Delivery?


Injectable drug delivery systems face challenges such as the need for precise dosing and the risk of infections at the injection site. However, these challenges present opportunities for innovation. For example, the development of more sophisticated dosing technologies and better antiseptic measures can mitigate these risks. Additionally, there is a growing need for biodegradable and biocompatible materials in drug delivery systems to minimize adverse reactions and enhance patient safety. The increasing demand for personalized medicine and targeted drug delivery systems also provides significant opportunities for growth in this sector.

The Growth in the Injectable Drugs Delivery Market Is Driven by Several Factors…


The growth in the injectable drugs delivery market is driven by several factors, including the increasing prevalence of chronic diseases such as diabetes and rheumatoid arthritis, which require regular, precise dosing of medication. The rising demand for biologics and their compatibility with injectable delivery systems also significantly contributes to market growth. Technological advancements that enhance patient compliance and reduce adverse effects are key growth drivers. Additionally, the growing focus on personalized medicine and the development of targeted delivery systems that improve therapeutic outcomes are major factors supporting the expansion of this market. Economic trends, such as increasing healthcare spending and the expansion of healthcare facilities worldwide, further drive the demand for advanced injectable drug delivery solutions. Collectively, these factors underscore the dynamic growth prospects of the injectable drugs delivery market, reflecting its essential role in modern healthcare.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Devices segment, which is expected to reach US$1.4 Trillion by 2030 with a CAGR of a 9.8%. The Formulations segment is also set to grow at 11.1% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $285.5 Billion in 2023, and China, forecasted to grow at an impressive 9.4% CAGR to reach $305.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Injectable Drugs Delivery Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Injectable Drugs Delivery Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Injectable Drugs Delivery Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Baxter International, Inc., Becton, Dickinson and Company, Elcam Medical, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 38 Featured):

  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Elcam Medical
  • Eli Lilly and Company
  • Gerresheimer AG
  • INJEX Pharma GmbH
  • Novartis International AG
  • Novo Nordisk A/S
  • SCHOTT AG
  • Terumo Corporation
  • Teva Pharmaceuticals USA, Inc.
  • West Pharmaceutical Services, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Injectable Drugs Delivery - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Diseases Spurs Growth in Injectable Drug Delivery Market
  • Advancements in Biologic Drugs Propel Demand for Specialized Injectable Delivery Systems
  • Growing Focus on Patient Compliance and Convenience Drives Innovation in Auto-Injectors and Pen Devices
  • Rising Demand for Targeted Therapies Strengthens Business Case for Injectable Drug Delivery
  • The Role of Injectable Delivery in Enhancing Bioavailability of Complex Drugs Fuels Market Growth
  • Growing Adoption of Injectable Drug Delivery in Oncology Expands Market Potential
  • Increasing Use of Injectable Delivery Systems in Vaccinations Generates Demand in Preventive Healthcare
  • Rising Incidence of Diabetes Drives Adoption of Insulin Pens and Other Injectable Devices
  • The Impact of Technological Innovations in Prefilled Syringes and Cartridges on the Injectable Drug Delivery Market
  • Focus on Reducing Injection Pain and Improving User Experience Drives Development of Needle-Free Injectors
  • Growing Investments in Biopharmaceuticals Expand Market for Injectable Drug Delivery Systems
  • Growing Trend of Personalized Medicine Sustains Market Growth for Customized Injectable Delivery Systems
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Injectable Drugs Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Injectable Drugs Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Injectable Drugs Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Formulations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Injectable Drugs Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 23: USA Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
CANADA
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
JAPAN
  • Injectable Drugs Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
CHINA
  • Injectable Drugs Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 38: China Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: China 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 41: China Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: China 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
EUROPE
  • Injectable Drugs Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Injectable Drugs Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Injectable Drugs Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
FRANCE
  • Injectable Drugs Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 53: France Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: France 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 56: France Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: France 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
GERMANY
  • Injectable Drugs Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Germany 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
ITALY
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Italy 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Injectable Drugs Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 71: UK Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: UK 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 74: UK Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Rest of Europe Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Rest of Europe 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Rest of Europe Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Rest of Europe 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Injectable Drugs Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Asia-Pacific Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Asia-Pacific 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Asia-Pacific Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Asia-Pacific 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
REST OF WORLD
  • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of World Historic Review for Injectable Drugs Delivery by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of World 16-Year Perspective for Injectable Drugs Delivery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2014, 2024 & 2030
  • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Injectable Drugs Delivery by Type - Devices and Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of World Historic Review for Injectable Drugs Delivery by Type - Devices and Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of World 16-Year Perspective for Injectable Drugs Delivery by Type - Percentage Breakdown of Value Sales for Devices and Formulations for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Elcam Medical
  • Eli Lilly and Company
  • Gerresheimer AG
  • INJEX Pharma GmbH
  • Novartis International AG
  • Novo Nordisk A/S
  • SCHOTT AG
  • Terumo Corporation
  • Teva Pharmaceuticals USA, Inc.
  • West Pharmaceutical Services, Inc.

Table Information